Zynerba Pharmaceuticals Inc (ZYNE) stock is higher by 61.54% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ZYNE stock a score of 61 out of a possible 100.
That rank is influenced by a long-term technical score of 100. ZYNE's rank also includes a short-term technical score of 80. ZYNE has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on ZYNE!